ArticleFrontiers in cardiovascular medicine2026
Non-enhanced CT-based radiomics signature of epicardial adipose tissue for screening coronary heart disease.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Our study aimed to establish a predictive model based on non-enhanced CT imaging features of epicardial adipose tissue (EAT) to differentiate patients with coronary heart disease (CHD) from those without. Methods: In this radiomics study, we collected clinical and radiomic data from a total of 281 patients diagnosed with CHD at the China-Japan Friendship Hospital, along with 188 healthy individuals who underwent physical examinations at our hospital. The participants were allocated to either a training or validation group at random, following a 7:3 ratio. We performed multivariate logistic regression analysis to create a clinical model, using a significance threshold of Results: In this radiomics study, the AUC of the clinical model were 0.883 (95% CI: 0.848-0.918) for the training cohort and 0.872 (95% CI: 0.812-0.932) for the validation cohort. In the radiomics model, the AUC for the training cohort was 0.853 (95% CI: 0.814-0.892) and for the validation cohort, it was 0.822 (95% CI: 0.751-0.893). DeLong's test revealed no significant difference in AUC between the clinical and radiomics models in both the training cohort ( Conclusions: Our findings indicate that the combined model, which incorporated clinical features and the radiomics signature of EAT, can serve as a valuable tool for distinguishing patients with and without CHD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.